FF
TAK icon

FourThought Financial’s Takeda Pharmaceutical TAK Stock Holding History

FourThought Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
12
– – ﹤0.01% 1567
2022
Q2 		$0 Hold
12
– – ﹤0.01% 1547
2022
Q1 		$0 Sell
12
-110
-90% -$1.61K ﹤0.01% 1564
2021
Q4 		$2K Hold
122
– – ﹤0.01% 1390
2021
Q3 		$1K Hold
122
– – ﹤0.01% 1503
2021
Q2 		$2K Hold
122
– – ﹤0.01% 1388
2021
Q1 		$2K Hold
122
– – ﹤0.01% 1341
2020
Q4 		$2K Buy
+122
New +$2.14K ﹤0.01% 1321

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

FourThought Financial's TAK Position: Q3 2022 in Review

FourThought Financial held its Takeda Pharmaceutical (TAK) position steady in Q3 2022 at 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

FourThought Financial first reported a position in TAK in Q4 2020 and has held it in 8 quarters since. The position peaked at $2K in Q4 2021. 277 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

  • FourThought Financial held 12 shares of Takeda Pharmaceutical worth $0 as of Q3 2022.
  • FourThought Financial left its Takeda Pharmaceutical share count unchanged in Q3 2022.
  • Takeda Pharmaceutical made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1567 holding.
  • FourThought Financial first reported a position in Takeda Pharmaceutical in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Takeda Pharmaceutical position peaked at $2K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.